Special Issue "Prevention and Treatment of Gestational Diabetes"

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Obstetrics and Gynecology".

Deadline for manuscript submissions: 15 April 2022.

Special Issue Editor

Dr. Tiziana Filardi
E-Mail Website
Guest Editor
Department of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy
Interests: endocrinology; metabolic diseases; type 2 diabetes; type 1 diabetes; gestational diabetes

Special Issue Information

Dear Colleagues,

The prevalence of gestational diabetes has significantly increased over the last few years, in line with the dramatic rise in obesity and type 2 diabetes. This condition significantly impacts maternal and fetal health, leading to short-term and long-term adverse outcomes for both mothers and their offspring.

The purpose of this Special Issue is to discuss different aspects of gestational diabetes, which might help to strengthen prevention and treatment strategies. Specifically, the role of emerging risk factors and novel biomarkers with potential diagnostic and prognostic utility will be examined, as well as the impact of both well-established and new therapeutic strategies on short- and long-term clinical outcomes of pregnancy complicated by gestational diabetes. Furthermore, developments in the understanding of the pathophysiological aspects of this condition will also be explored. Research articles, review articles, as well as short communications are invited.

Dr. Tiziana Filardi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gestational diabetes risk
  • gestational diabetes prevention
  • gestational diabetes pathophysiology
  • novel diagnostic biomarkers for gestational diabetes
  • treatment strategies for gestational diabetes
  • maternal outcomes of gestational diabetes
  • fetal outcomes of gestational diabetes
  • long-term complications of gestational diabetes

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Review
Negotiating Gestational Diabetes Mellitus in India: A National Approach
Medicina 2021, 57(9), 942; https://0-doi-org.brum.beds.ac.uk/10.3390/medicina57090942 - 06 Sep 2021
Viewed by 654
Abstract
The worldwide epidemic of diabetes mellitus and hyperglycemia in pregnancy (HIP) presents many challenges, some of which are country-specific. To address these specific problems, parochial resolutions are essential. In India, the government, by working in tandem with (a) national groups such as the [...] Read more.
The worldwide epidemic of diabetes mellitus and hyperglycemia in pregnancy (HIP) presents many challenges, some of which are country-specific. To address these specific problems, parochial resolutions are essential. In India, the government, by working in tandem with (a) national groups such as the Diabetes in Pregnancy Study Group of India, and (b) global organizations such as the International Diabetes Federation, has empowered the medical and paramedical staff throughout the country to manage HIP. Additionally, despite their academic university backgrounds, Indian health planners have provided practical guidelines for caregivers at the ground level, who look up to these experts for guidance. This multipronged process has helped to negotiate some of the multiple problems that are indigenous and exclusive to India. This review traces the Indian journey to manage and prevent HIP with simple, constructive, and pragmatic solutions. Full article
(This article belongs to the Special Issue Prevention and Treatment of Gestational Diabetes)
Show Figures

Figure 1

Back to TopTop